KATY FINNEY: Open Payments
NPI 1538545660 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,521 in 64 payments from 13 companies in 2025. Trend: 2023 $944 · 2024 $2,717 · 2025 $2,521
Food & beverage: $2,209Travel & lodging: $313
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 14 | $1,050 |
| Amgen Inc. | 10 | $427 |
| Actelion Pharmaceuticals US, Inc. | 4 | $196 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $167 |
| E.R. Squibb & Sons, L.L.C. | 3 | $164 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $153 |
| Novartis Pharmaceuticals Corporation | 4 | $101 |
| Boston Scientific Corporation | 4 | $84 |
| PFIZER INC. | 4 | $71 |
| SCPHARMACEUTICALS INC. | 3 | $52 |
Products named: CARDIOMEMS, JARDIANCE, CAMZYOS, Kerendia, AVEIR, UPTRAVI, LEQVIO, REPATHA.
Industry payments across TX — which companies pay providers there.
